Lenvatinib for Anaplastic Thyroid Cancer and Lenvatinib-Induced Thyroid Dysfunction
Conclusions: Lenvatinib is an effective treatment and may improve the prognosis of unresectable ATC. Four of the 5 patients had hypothyroidism, which may have been associated with treatment-induced injury of the thyroid gland. There were many treatment-related adverse effects, most of which were manageable by dose modification and medical therapy.Eur Thyroid J
Source: European Thyroid Journal - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Endocrinology | Hypertension | Hypothyroidism | Oral Cancer | Study | Thyroid | Thyroid Cancer | Thyroidectomy | Toxicology